Operating

Contingent consideration fair value adjustments

Rocket Lab USA, Inc. Contingent consideration fair value adjustments increased by 101.8% to $187.00K in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ1 2026May 7, 2026

How to read this metric

Increases often signal that acquired assets are performing better than expected, requiring higher future payouts, while decreases may suggest lower-than-anticipated success in R&D milestones.

Detailed definition

This reflects the periodic adjustments to the fair value of earn-out provisions or milestone payments related to past bu...

Peer comparison

Standard for R&D-heavy firms that frequently acquire biotech companies with milestone-based deal structures.

Metric ID: operating_business_combination_contingent_consideration__7f0be7

Historical Data

14 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q4 '23Q1 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$2.50M-$2.50M$200.00K-$200.00K$300.00K$1.30M$205.00K-$271.00K$0.00$0.00$0.00-$10.62M$187.00K
QoQ Change-200.0%+108.0%-200.0%+250.0%+333.3%-84.2%-232.2%+100.0%+101.8%
YoY Change-88.0%+152.0%+202.5%-190.3%+100.0%
Range-$10.62M$2.50M
Avg YoY Growth+35.2%
Median YoY Growth+100.0%

Contingent consideration fair value adjustments at Other Companies

Frequently Asked Questions

What is Rocket Lab USA, Inc.'s contingent consideration fair value adjustments?
Rocket Lab USA, Inc. (RKLB) reported contingent consideration fair value adjustments of $187.00K in Q1 2026.
What does contingent consideration fair value adjustments mean?
Changes in the estimated cost of future payments owed to sellers of acquired companies based on performance milestones.